Genkyotex announces an Extraordinary Shareholders’ Meeting to be held on January 24, 2019 at 10 am and confirms the key development milestone for GKT831 in PBC
Genkyotex Meets Both Primary and Secondary Interim Efficacy Endpoints in Phase 2 Trial of GKT831 in Primary Biliary Cholangitis
Genkyotex Announces Positive Outcome from the Independent SMB’s Third Pre-Planned Review of the Phase 2 Trial of GKT831 in Primary Biliary Cholangitis
Genkyotex provides corporate update and reports cash position at September 30, 2018
Genkyotex Announces Presentation of GKT831 Efficacy Data in a Preclinical Model of Advanced Cholestatic Liver Disease at AASLD Liver Meeting® 2018
Preclinical Efficacy of Genkyotex’s GKT831 in Prostate Cancer Presented at ESUR18 Meeting
Genkyotex Announces First-Half 2018 Financial Results
Genkyotex Exceeds Patient Enrollment Target in its Phase 2 Trial with GKT831 for Primary Biliary Cholangitis
Genkyotex Announces Positive Outcome from the Second Independent SMB Review of the Phase 2 Trial of GKT831 in PBC
Genkyotex Announces Completion of Enrollment in Interim Analysis Cohort of Phase 2 Trial of GKT831 in Primary Biliary Cholangitis
Genkyotex secures an up to €7.5 million gross financing to further expand the development of its lead product
Genkyotex Announces Investigator-Initiated Phase 2 Clinical Trial to be Conducted with GKT831 in Patients with Idiopathic Pulmonary Fibrosis
Genkyotex Provides Update on PBC Phase 2 Trial And Reports June 30, 2018, Cash Position
Genkyotex Expands License Agreement for Vaxiclase Platform with Serum Institute of India
Genkyotex announces positive outcome from ISMB's first review of GKT831's phase 2 trial in PBC
Genkyotex reports March 31, 2018 cash position and provides business update
Genkyotex to Present Corporate Overview at H. C. Wainwright Annual Global Life Sciences Conference
Genkyotex to Present Corporate Overview at 30th Annual ROTH Conference
Genkyotex Announces 2017 Annual Financial Results
Genkyotex's Lead Product Candidate, GKT831, Halts the Tumor Promoting Effect of Cancer Associated Fibroblasts
Genkyotex reports December 31, 2017 cash position and provides business update
Ask us your questions
Suscribe to Newsletter
